Passage of SB1580 would expand the Right to Try Act to enable patients suffering from chronic diseases to access medications and treatments not yet given final approval for use by the FDA.
The post Texas Bill Would Expand State Right to Try; Further Reject Some FDA Restrictions on Experimental Treatments first appeared on Tenth Amendment Center.
The enactment of SB422 would expand the law to enable any patient to access medications and treatments not yet given final approval for use by the FDA. SB422 would simply remove all patient eligibility requirements from the current law.
The post Montana Senate Passes Bill to Expand Right to Try Act; Further Reject Some FDA Restrictions on Experimental Treatments first appeared on Tenth Amendment Center.
The legislation is an expansion of the Texas Right to Try law that went into effect in June 2015. The law enables terminally ill patients to access medications and treatments that do not have final FDA approval. Passage of SB773 would expand that to enable patients suffering from chronic diseases to access medications and treatments not yet given final approval for use by the FDA.
The post Texas Bill Would Expand State Right to Try; Further Reject Some FDA Restrictions on Experimental Treatments first appeared on Tenth Amendment Center.
The legislation would enable patients suffering from chronic diseases to access medications and treatments not yet given final approval for use by the FDA.
The post Texas Bill Would Expand State Right to Try; Further Reject Some FDA Restrictions on Experimental Treatments first appeared on Tenth Amendment Center.
HARRISBURG, Pa. (Sept. 26, 2018) – A bill introduced in the Pennsylvania House would expand the states “Right to Try” law and would set the foundation to further nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally and chronically ill patients. A bipartisan coalition of 19 sponsors introduced […]
A lot of our work goes on behind the scenes. As a result, it can often go unnoticed. So, it’s nice when the legislators and other elected officials we work with acknowledge the effort we put in. That happened recently when Alaska Gov. Bill Walker invited me to the bill signing ceremony for the Alaska…
LINCOLN, Neb. (July 19, 2018) – Today, a Nebraska law went into effect that allows terminally ill patients to bypass some Food and Drug Administration (FDA) rules that deny access to experimental treatments. Sen. Bob Hilkemann (R-Omaha) introduced Legislature Bill 117 (LB117) last year and it carried over into the 2018 session. The new law…
JUNEAU, Alaska (July 16, 2018) – On Friday, Alaska Gov. Bill Walker signed a bill into law that allows terminally ill patients to bypass some Food and Drug Administration (FDA) rules that deny access to experimental treatments. Rep. Jason Grenn (I-Anchorage) introduced House Bill 43 (HB43) last year. The law gives terminally ill patients access…
WASHINGTON (May 23, 2018) – The U.S. House gave final approval to federal Right to Try law that will allow terminally ill patients to access investigational treatments that have not received final FDA approval. Passage of this bill was a direct result of action that started in the states five years ago. The U.S. Senate…
PROVIDENCE, R.I. (May 16, 2018) – Today, the Rhode Island House passed a bill would nullify in practice some Food and Drug Administration (FDA) rules that deny access to experimental treatments by terminally ill patients. Rep. Joseph McNamara (D-Warwick) introduced House Bill 7294 (H7294) in January along with four bipartisan co-sponsors. The legislation would allow…